Tamoxifen retards glycosphingolipid metabolism in human cancer cells
- PMID: 8843149
- DOI: 10.1016/0014-5793(96)00942-8
Tamoxifen retards glycosphingolipid metabolism in human cancer cells
Abstract
In this study we provide evidence that tamoxifen, the widely used breast cancer drug, is a potent antagonist of glycolipid metabolism. When added to the medium of cultured multidrug resistant (MDR) KB-V-1 carcinoma cells, tamoxifen, at 5.0 microM, drastically lowered the levels of glucosylceramide (glc-cer), as evidenced by a reduction in glc-cer mass. In a similar fashion, in cultured human melanoma cells grown with [3H]galactose, tamoxifen inhibited formation of glc-cer by 44%, and retarded lactosylceramide and ganglioside formation by 50 and 35%, respectively. When glc-cer synthase of melanoma was assayed in cell-free incubations, the inclusion of tamoxifen, at a 1:10 molar ratio with ceramide, inhibited glc-cer synthesis by 50%. These results clearly reveal a new action of tamoxifen and thereby pose intriguing questions regarding mechanisms of action in the realm of estrogen receptor-independent modalities, including effects on MDR.
Similar articles
-
Agents that reverse multidrug resistance, tamoxifen, verapamil, and cyclosporin A, block glycosphingolipid metabolism by inhibiting ceramide glycosylation in human cancer cells.J Biol Chem. 1997 Jan 17;272(3):1682-7. doi: 10.1074/jbc.272.3.1682. J Biol Chem. 1997. PMID: 8999846
-
P-glycoprotein antagonists confer synergistic sensitivity to short-chain ceramide in human multidrug-resistant cancer cells.Exp Cell Res. 2011 Jul 15;317(12):1736-45. doi: 10.1016/j.yexcr.2011.03.004. Epub 2011 Mar 21. Exp Cell Res. 2011. PMID: 21396934 Free PMC article.
-
Multidrug resistance modulators and doxorubicin synergize to elevate ceramide levels and elicit apoptosis in drug-resistant cancer cells.Cancer. 1999 Jul 15;86(2):300-11. doi: 10.1002/(sici)1097-0142(19990715)86:2<300::aid-cncr14>3.0.co;2-h. Cancer. 1999. PMID: 10421266
-
Tamoxifen regulation of sphingolipid metabolism--Therapeutic implications.Biochim Biophys Acta. 2015 Sep;1851(9):1134-45. doi: 10.1016/j.bbalip.2015.05.001. Epub 2015 May 9. Biochim Biophys Acta. 2015. PMID: 25964209 Free PMC article. Review.
-
Update on Glycosphingolipids Abundance in Hepatocellular Carcinoma.Int J Mol Sci. 2022 Apr 19;23(9):4477. doi: 10.3390/ijms23094477. Int J Mol Sci. 2022. PMID: 35562868 Free PMC article. Review.
Cited by
-
Bacterial diet modulates tamoxifen-induced death via host fatty acid metabolism.Nat Commun. 2022 Sep 23;13(1):5595. doi: 10.1038/s41467-022-33299-5. Nat Commun. 2022. PMID: 36151093 Free PMC article.
-
Recent advances in the immunobiology of ceramide.Exp Mol Pathol. 2007 Jun;82(3):298-309. doi: 10.1016/j.yexmp.2006.07.009. Epub 2006 Oct 12. Exp Mol Pathol. 2007. PMID: 17045585 Free PMC article. Review.
-
Modification of sphingolipid metabolism by tamoxifen and N-desmethyltamoxifen in acute myelogenous leukemia--Impact on enzyme activity and response to cytotoxics.Biochim Biophys Acta. 2015 Jul;1851(7):919-28. doi: 10.1016/j.bbalip.2015.03.001. Epub 2015 Mar 10. Biochim Biophys Acta. 2015. PMID: 25769964 Free PMC article.
-
Leishmania is not prone to develop resistance to tamoxifen.Int J Parasitol Drugs Drug Resist. 2015 Jun 17;5(3):77-83. doi: 10.1016/j.ijpddr.2015.05.006. eCollection 2015 Dec. Int J Parasitol Drugs Drug Resist. 2015. PMID: 26150922 Free PMC article.
-
Treating glucosphingolipid disorders by chemotherapy: use of approved drugs and over-the-counter remedies.J Inherit Metab Dis. 2000 Dec;23(8):767-77. doi: 10.1023/a:1026796200760. J Inherit Metab Dis. 2000. PMID: 11196103 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
